Cost is often a barrier for NIPT screening, but is it a screening test every pregnant woman should have?
Non-invasive prenatal testing, or NIPT, is a highly accurate screening test for Down syndrome, Edwards syndrome, Patau syndrome and (if selected) DiGeorge syndrome.
Dr Melody Caramins, genetic pathologist, told an audience at the GP19 conference in Adelaide said the test should be offered to all pregnant women.
But the cost of the screening is a significant barrier for patients in Australia.
In this bonus episode, Dr Caramins explains NIPT and its suitability in practice.
You can subscribe to The Medical Republic podcast on iTunes, Spotify via the RSS feed or wherever you get your podcasts by searching for âThe Medical Republicâ.
